SCHEMBL5084368

SCHEMBL5084368

Brc1ccc2ccccc2c1.ClC1=C(Cl)C(Cl)(Cl)C(Cl)=C1Cl.ClC1=C(Cl)C(Cl)(Cl)C(Cl)=C1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.65
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
TSHR P16473 1/20 0.42
HIF1A Q16665 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
CYP1A2 P05177 3/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
KDM1A O60341 2/20 0.36
RCOR1 Q9UKL0 2/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
DHODH Q02127 1/20 0.35
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL5080748 0.83 TSHR (0.61) CYP2A6ALDH1A1TDP1TSHRHIF1A
SCHEMBL154221 0.81 CYP2A6 (1.00) CYP2A6ALDH1A1TDP1MEN1KMT2A
SCHEMBL29485684 0.81 CYP2A6 (1.00) CYP2A6ALDH1A1TDP1MEN1KMT2A
SCHEMBL5083606 0.79 CYP2A6 (0.63) CYP2A6ALDH1A1TDP1TSHRHIF1A
SCHEMBL1120140 0.79 CYP2A6 (0.94) CYP2A6ALDH1A1TDP1MEN1KMT2A
SCHEMBL22909955 0.79 CYP2A6 (0.94) CYP2A6ALDH1A1TDP1MEN1KMT2A
SCHEMBL29002798 0.79 CYP2A6 (0.94) CYP2A6ALDH1A1TDP1MEN1KMT2A
Benzene SCHEMBL27861653 0.79 CYP2A6 (0.94) CYP2A6ALDH1A1TDP1MEN1KMT2A
SCHEMBL9727032 0.78 CYP2A6 (0.74) CYP2A6ALDH1A1TDP1MEN1KMT2A
Formaldehyde SCHEMBL28823619 0.74 CYP2A6 (0.85) CYP2A6ALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076375-B2 Methods of inhibiting poxvirus growth THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2011-12-13 US disclosed
US-20080306031-A1 Methods of Inhibiting Poxvirus Growth SALK INSTITUTE FOR BIOLOGICAL STUDIES 2008-12-11 US disclosed
WO-2007047339-A2 METHODS OF INHIBITING POXVIRUS GROWTH THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306031-A1 Methods of Inhibiting Poxvirus Growth TTK, TXK, DCK CYP2A6 4109/4885ALDH1A1 4581/4885TDP1 3150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.